A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, open-labeled study to examine the non-inferiority of ASP1585 to
sevelamer hydrochloride in chronic kidney disease patients with hyperphosphatemia on
hemodialysis.